{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immunity",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:23725625",
      "entity_text" : "olaparib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Together, these data suggest that olaparib treatment triggered a robust antitumor immunity in the PBM tumor microenvironment involving both adaptive and innate immune responses with activation of lymphoid and myeloid derived cells.",
  "reading_complete" : "2020-08-09T05:44:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T05:42:27Z",
  "trigger" : "triggered",
  "evidence" : [ "olaparib treatment triggered a robust antitumor immunity" ],
  "pmc_id" : "6366450",
  "score" : 0
}